ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,320.76
0.43%
Dow Jones
42,445.08
0.64%
Gold vs US Dollar
2,647.78
-0.93%
Brent Oil
71.82
1.23%
Bitcoin
66,078.08
1.37%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aurinia Pharmaceuticals Inc (AUPH) Share Price

AUPH Aurinia Pharmaceuticals Inc

7.165
0.005 (0.07%)
Last Updated: 17:01:57
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Aurinia Pharmaceuticals Inc NASDAQ:AUPH NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.005 0.07 7.165 7.16 7.17 7.23 7.11 7.21 154,552 16:01:57   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 175.51M -78.02M -0.5456 -13.20 1.02B
 Type  Size  Price  Time  Units 
 9 2 7.1647 16:06:03 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore AUPH News
24/09/202413:10BWAurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis
20/09/202421:56EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
13/09/202411:00BWAurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference
12/09/202421:08EDGAR2Form 8-K - Current report
12/09/202421:05BWAurinia Announces Board Restructuring
05/09/202411:00BWAurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial
28/08/202411:00BWAurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference
Period
Draw mode
Data Downloads for AUPH

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Aurinia Pharmaceuticals Inc Articles